ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung Cancer

Published:2017-04-12 Issue:5 Volume:14 Page:1782-1789
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Ehlerding Emily B.¹,England Christopher G.¹,Majewski Rebecca L.²,Valdovinos Hector F.¹,Jiang Dawei³,Liu Glenn⁴,McNeel Douglas G.⁴,Nickles Robert J.¹,Cai Weibo¹²³^ORCID

Affiliation:

1. Department of Medical Physics, University of Wisconsin−Madison, Madison, Wisconsin 53705, United States

2. Department of Biomedical Engineering, University of Wisconsin−Madison, Madison, Wisconsin 53705, United States

3. Department of Radiology, University of Wisconsin−Madison, Madison, Wisconsin 53705, United States

4. Department of Medicine, University of Wisconsin−Madison, Madison, Wisconsin 53705, United States

Funder

National Cancer Institute

National Institute of Biomedical Imaging and Bioengineering

American Cancer Society

University of Wisconsin-Madison

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.7b00056

Reference29 articles.

1. Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade

2. At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy

3. Ipilimumab in the treatment of advanced melanoma – a clinical update

4. Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma

5. Association of PDCD1 and CTLA-4 Gene Expression with Clinicopathological Factors and Survival in Non–Small-Cell Lung Cancer: Results from a Large and Pooled Microarray Database

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Illuminating immunotherapy response via precision T cell-targeted PET imaging;Frontiers in Medicine;2024-07-22

2. Construction and Preclinical Evaluation of ¹²⁴I/¹²⁵I-Labeled Antibody Targeting T Cell Immunoglobulin and Mucin Domain-3;Molecular Pharmaceutics;2024-01-25

3. Clinical Application of ImmunoPET Targeting Checkpoint Inhibitors;Cancers;2023-11-30

4. Current and potential roles of immuno-PET/-SPECT in CAR T-cell therapy;Frontiers in Medicine;2023-06-27

5. Aptamer-Based Immunotheranostic Strategies;Cancer Biotherapy and Radiopharmaceuticals;2023-05-01